61 related articles for article (PubMed ID: 22776842)
1. High expression of LMO2 in Hodgkin, Burkitt and germinal center diffuse large B cell lymphomas.
Shams TM
J Egypt Natl Canc Inst; 2011 Dec; 23(4):147-53. PubMed ID: 22776842
[TBL] [Abstract][Full Text] [Related]
2. Alternative and canonical NF-kB pathways DNA-binding hierarchies networks define Hodgkin lymphoma and Non-Hodgkin diffuse large B Cell lymphoma respectively.
Gamboa-Cedeño AM; Castillo M; Xiao W; Waldmann TA; Ranuncolo SM
J Cancer Res Clin Oncol; 2019 Jun; 145(6):1437-1448. PubMed ID: 30941572
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus infection and expression of B-cell oncogenic markers in HIV-related diffuse large B-cell Lymphoma.
Chao C; Silverberg MJ; Martínez-Maza O; Chi M; Abrams DI; Haque R; Zha HD; McGuire M; Xu L; Said J
Clin Cancer Res; 2012 Sep; 18(17):4702-12. PubMed ID: 22711707
[TBL] [Abstract][Full Text] [Related]
4. DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control.
Kretzmer H; Bernhart SH; Wang W; Haake A; Weniger MA; Bergmann AK; Betts MJ; Carrillo-de-Santa-Pau E; Doose G; Gutwein J; Richter J; Hovestadt V; Huang B; Rico D; Jühling F; Kolarova J; Lu Q; Otto C; Wagener R; Arnolds J; Burkhardt B; Claviez A; Drexler HG; Eberth S; Eils R; Flicek P; Haas S; Humme M; Karsch D; Kerstens HHD; Klapper W; Kreuz M; Lawerenz C; Lenzek D; Loeffler M; López C; MacLeod RAF; Martens JHA; Kulis M; Martín-Subero JI; Möller P; Nage I; Picelli S; Vater I; Rohde M; Rosenstiel P; Rosolowski M; Russell RB; Schilhabel M; Schlesner M; Stadler PF; Szczepanowski M; Trümper L; Stunnenberg HG; Küppers R; Ammerpohl O; Lichter P; Siebert R; Hoffmann S; Radlwimmer B
Nat Genet; 2015 Nov; 47(11):1316-1325. PubMed ID: 26437030
[TBL] [Abstract][Full Text] [Related]
5. Activation of the
Rahman S; Magnussen M; León TE; Farah N; Li Z; Abraham BJ; Alapi KZ; Mitchell RJ; Naughton T; Fielding AK; Pizzey A; Bustraan S; Allen C; Popa T; Pike-Overzet K; Garcia-Perez L; Gale RE; Linch DC; Staal FJT; Young RA; Look AT; Mansour MR
Blood; 2017 Jun; 129(24):3221-3226. PubMed ID: 28270453
[TBL] [Abstract][Full Text] [Related]
6. LIM domain only-2 (LMO2) induces T-cell leukemia by two distinct pathways.
Smith S; Tripathi R; Goodings C; Cleveland S; Mathias E; Hardaway JA; Elliott N; Yi Y; Chen X; Downing J; Mullighan C; Swing DA; Tessarollo L; Li L; Love P; Jenkins NA; Copeland NG; Thompson MA; Du Y; Davé UP
PLoS One; 2014; 9(1):e85883. PubMed ID: 24465765
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive analysis of LMO2 pathogenic regulatory profile during T-lineage development and leukemic transformation.
Wang W; Meng Y; Chen Y; Yu Y; Wang H; Yang S; Sun W
Oncogene; 2022 Aug; 41(34):4079-4090. PubMed ID: 35851847
[TBL] [Abstract][Full Text] [Related]
8. Aggressive non-Hodgkin lymphoma in the pediatric and young adult population; diagnostic and molecular pearls of wisdom.
Singh A; Obiorah IE
Semin Diagn Pathol; 2023 Nov; 40(6):392-400. PubMed ID: 37400280
[TBL] [Abstract][Full Text] [Related]
9. Identification of a minority population of LMO2
Sikandar SS; Gulati GS; Antony J; Fetter I; Kuo AH; Ho WHD; Haro-Acosta V; Das S; Steen CB; Pereira TA; Qian D; Beachy PA; Dirbas FM; Red-Horse K; Rabbitts TH; Thiery JP; Newman AM; Clarke MF
Sci Adv; 2022 Nov; 8(45):eabm3548. PubMed ID: 36351009
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic utility of LMO2 immunohistochemistry in distinguishing T-lymphoblastic leukemia/lymphoma from thymoma.
Bansal D; Pasricha S; Gupta G; Sharma A; Durga G; Kamboj M; Mehta A
Indian J Pathol Microbiol; 2024; 67(1):141-144. PubMed ID: 38358204
[TBL] [Abstract][Full Text] [Related]
11. AMG176, an MCL-1 inhibitor, is active in pre-clinical models of aggressive B-cell lymphomas.
Torka P; Russell T; Mavis C; Gu J; Ghione P; Barth M; Hernandez-Ilizaliturri FJ
Leuk Lymphoma; 2023 Jun; 64(6):1175-1185. PubMed ID: 37074033
[TBL] [Abstract][Full Text] [Related]
12. A cell-based screening method using an intracellular antibody for discovering small molecules targeting the translocation protein LMO2.
Bery N; Bataille CJR; Russell A; Hayes A; Raynaud F; Milhas S; Anand S; Tulmin H; Miller A; Rabbitts TH
Sci Adv; 2021 Apr; 7(15):. PubMed ID: 33837087
[TBL] [Abstract][Full Text] [Related]
13. Competitive SPR using an intracellular anti-LMO2 antibody identifies novel LMO2-interacting compounds.
Canning P; Bataille C; Bery N; Milhas S; Hayes A; Raynaud F; Miller A; Rabbitts T
J Immunol Methods; 2021 Jul; 494():113051. PubMed ID: 33794223
[TBL] [Abstract][Full Text] [Related]
14. Compromised counterselection by FAS creates an aggressive subtype of germinal center lymphoma.
Razzaghi R; Agarwal S; Kotlov N; Plotnikova O; Nomie K; Huang DW; Wright GW; Smith GA; Li M; Takata K; Yamadi M; Yao C; O'Shea JJ; Phelan JD; Pittaluga S; Scott DW; Muppidi JR
J Exp Med; 2021 Mar; 218(3):. PubMed ID: 33237303
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological Characteristics and Prognosis of Diffuse Large B-Cell Lymphoma in Relation to CA-125 and CA 19-9 Expression.
Foda AAM; Atia T; Sakr HI; Abd Elaziz Ahmed Elnaghi K; Abdelhay WM; Enan ET
J Evid Based Integr Med; 2023; 28():2515690X231198315. PubMed ID: 37654084
[No Abstract] [Full Text] [Related]
16. Conditional expression of HGAL leads to the development of diffuse large B-cell lymphoma in mice.
Raboso-Gallego J; Casado-García A; Jiang X; Isidro-Hernández M; Gentles AJ; Zhao S; Natkunam Y; Blanco O; Domínguez V; Pintado B; Alonso-López D; De Las Rivas J; Vicente-Dueñas C; Lossos IS; Sanchez-Garcia I
Blood; 2021 Apr; 137(13):1741-1753. PubMed ID: 33024996
[TBL] [Abstract][Full Text] [Related]
17. LMO2 is essential to maintain the ability of progenitors to differentiate into T-cell lineage in mice.
Hirano KI; Hosokawa H; Koizumi M; Endo Y; Yahata T; Ando K; Hozumi K
Elife; 2021 Aug; 10():. PubMed ID: 34382935
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical and other prognostic factors in B cell non Hodgkin lymphoma patients, Kampala, Uganda.
Tumwine LK; Agostinelli C; Campidelli C; Othieno E; Wabinga H; Righi S; Falini B; Piccaluga PP; Byarugaba W; Pileri SA
BMC Clin Pathol; 2009 Dec; 9():11. PubMed ID: 20003543
[TBL] [Abstract][Full Text] [Related]
19. PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma.
D'Avola A; Legrave N; Tajan M; Chakravarty P; Shearer RL; King HW; Kluckova K; Cheung EC; Clear AJ; Gunawan AS; Zhang L; James LK; MacRae JI; Gribben JG; Calado DP; Vousden KH; Riches JC
J Clin Invest; 2024 Feb; 134(4):. PubMed ID: 38357928
[No Abstract] [Full Text] [Related]
20. Different patterns of mast cell distribution in B-cell non-Hodgkin lymphomas.
Guidolin D; Tamma R; Annese T; Tortorella C; Ingravallo G; Gaudio F; Musto P; Specchia G; Ribatti D
Pathol Res Pract; 2023 Aug; 248():154661. PubMed ID: 37406375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
